Elhízás: nyitott vizsgálatok itt: Dánia
59 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. nov. 10.. Ask the study team whether a trial fits you.
3. fázisToborozTrial-stage medicine
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Aarhus N, Gandrup, Herlev, Holbæk, Hvidovre, Middelfart, Odense C, Vejle
- Age
- 18 év and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509EU 2025-523295-23-00Regiszter frissítve: 2026-11-09
No phaseToborzás még nem indultResearch participation
Effectiveness of a 10-week Multicomponent Intervention Combined With Parent Education on Binge Eating Behavior in Children and Adolescents
- Where
- Hobro, Kruså
- Age
- 7 év to 14 év
- People
- 200
- Run by
- University of Aarhus
See details and how to joinNCT07301541Regiszter frissítve: 2026-11-06
3. fázisToborozTrial-stage medicine
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
- Where
- Aarhus N, Herlev, Holbæk, Hvidovre, Slagelse
- Age
- 18 év and over
- People
- 3900 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07843498EU 2026-526188-39-00Regiszter frissítve: 2026-11-05
3. fázisToborzás még nem indultTrial-stage medicine
A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
- Where
- Esbjerg, Herning, Holbæk, Hvidovre, Viborg
- Age
- 18 év and over
- People
- 1408 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07919405Regiszter frissítve: 2026-11-05
3. fázisToborozTrial-stage medicine
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Aarhus, Copenhagen, Gistrup, Odense, Vejle
- Age
- 18 év to 70 év
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086EU 2024-520209-38-00Regiszter frissítve: 2026-11-04
3. fázisToborozTrial-stage medicine
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Aarhus, Copenhagen, Gistrup, Odense, Vejle
- Age
- 18 év to 70 év
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099EU 2024-520210-21-00Regiszter frissítve: 2026-11-04
3. fázisToborozTrial-stage medicine
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Where
- Gandrup, Herlev, Vejle
- Age
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07353931EU 2025-523768-19-00Regiszter frissítve: 2026-11-04
No phaseToborozResearch participation
Hypothalamic GLP-1 Response in Healthy Weight and Obesity
- Where
- Copenhagen
- Age
- 18 év to 75 év
- People
- 60
- Run by
- University of Copenhagen
See details and how to joinNCT07854886Regiszter frissítve: 2026-11-02
2. fázisToborzás még nem indultTrial-stage medicine
Semaglutide for Weight Management During Hormone Therapy for Early Breast Cancer
- Where
- Aarhus N
- Age
- 18 év and over
- People
- 32
- Run by
- Aarhus University Hospital
See details and how to joinNCT07909889Regiszter frissítve: 2026-11-02
3. fázisToborozTrial-stage medicine
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Aarhus N, Esbjerg, Frederiksberg, Herlev, Herning, Hvidovre, Roskilde
- Age
- 18 év to 99 év
- People
- 5056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459Regiszter frissítve: 2026-10-29
4. fázisToborozTrial-stage medicine
FutureShape Family
- Where
- Copenhagen
- Age
- 5 év and over
- People
- 400
- Run by
- Signe Torekov
See details and how to joinNCT07872904Regiszter frissítve: 2026-10-29
No phaseCsak meghívásosResearch participation
Sustaining Health After an Intensive Weight-loss Pro-gramme
- Where
- Copenhagen
- People
- 150
- Run by
- Copenhagen University Hospital, Hvidovre
See details and how to joinNCT07900178Regiszter frissítve: 2026-10-28
3. fázisToborozResearch participation
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- Esbjerg, Frederiksberg, Herlev, Herning, Hvidovre, Roskilde
- Age
- 18 év and over
- People
- 2787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00EU 2024-516654-22-00Regiszter frissítve: 2026-10-27
No phaseToborozResearch participation
Changes in Intestinal Permeability and Systemic Inflammation Following Fast Food Overfeeding.
- Where
- Hellerup
- Age
- 20 év to 40 év
- People
- 20
- Run by
- University Hospital, Gentofte, Copenhagen
See details and how to joinNCT07893743Regiszter frissítve: 2026-10-26
3. fázisToborzás még nem indultTrial-stage medicine
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
- Where
- Aabenraa, Aarhus N, Herlev, Herning, Hvidovre, Kolding
- Age
- 45 év to 64 év
- People
- 8500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07861100EU 2026-525182-53-00Regiszter frissítve: 2026-10-06
No phaseToborzás még nem indultResearch participation
Danish Trial of Weight Loss to Reduce Atrial Fibrillation Progression
- Where
- Copenhagen, Esbjerg
- Age
- 18 év and over
- People
- 480
- Run by
- Axel Brandes
See details and how to joinNCT07816744Regiszter frissítve: 2026-10-05
1. fázisToborozTrial-stage medicine
A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Overweight or Obesity, Compared to a Low-calorie Diet or Placebo
- Where
- Aarhus N
- Age
- 18 év and over
- People
- 120 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07757087EU 2025-522744-40-00Regiszter frissítve: 2026-10-01
3. fázisToborozTrial-stage medicine
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Where
- Holbæk
- Age
- 8 év to 18 év
- People
- 460 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07253285EU 2023-509176-42-00Regiszter frissítve: 2026-09-30
3. fázisToborozTrial-stage medicine
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
- Where
- Gandrup, Hellerup, Hilleroed, Hvidovre, Vejle
- Age
- 18 év and over
- People
- 1150 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07339423EU 2024-520440-42-00Regiszter frissítve: 2026-09-24
3. fázisToborozTrial-stage medicine
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Where
- Herning, Koege
- Age
- 18 év and over
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07571005EU 2024-520442-36-00Regiszter frissítve: 2026-09-11
1. fázisToborozTrial-stage medicine
The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
- Where
- Herlev
- Age
- 50 év to 70 év
- People
- 144
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07010432EU 2024-517883-49-00Regiszter frissítve: 2026-09-10
3. fázisToborozTrial-stage medicine
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- Where
- Aarhus N, Hellerup, Herning
- Age
- 18 év and over
- People
- 450 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07770841EU 2025-524626-18-00Regiszter frissítve: 2026-09-09
No phaseToborozResearch participation
Intensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Randomised Trial
- Where
- Aarhus, Esbjerg, Hvidovre, Viborg
- Age
- 18 év to 60 év
- People
- 500 worldwide
- Run by
- Carsten Dirksen
See details and how to joinNCT06309238Regiszter frissítve: 2026-08-21
3. fázisToborozTrial-stage medicine
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Aabenraa, Copenhagen Oe, Frederiksberg, Herlev, Hjoerring, Holbæk, Hvidovre, Svendborg, Viborg
- Age
- 18 év and over
- People
- 5610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001EU 2025-523717-29-00Regiszter frissítve: 2026-08-18
3. fázisToborozTrial-stage medicine
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Where
- Aarhus N, Frederiksberg, Herlev
- Age
- 18 év and over
- People
- 400 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07509307EU 2024-520445-23-00Regiszter frissítve: 2026-08-17
Minden vizsgálat (Elhízás) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.